These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 9568844

  • 1. Effects of vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF) on haemodynamics and permselectivity of the isolated perfused rat kidney.
    Klanke B, Simon M, Röckl W, Weich HA, Stolte H, Gröne HJ.
    Nephrol Dial Transplant; 1998 Apr; 13(4):875-85. PubMed ID: 9568844
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries.
    Ku DD, Zaleski JK, Liu S, Brock TA.
    Am J Physiol; 1993 Aug; 265(2 Pt 2):H586-92. PubMed ID: 8368362
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.
    Murohara T, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan A, Isner JM.
    Circulation; 1993 Aug; 97(1):99-107. PubMed ID: 9443437
    [Abstract] [Full Text] [Related]

  • 4. Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium.
    Horowitz JR, Rivard A, van der Zee R, Hariawala M, Sheriff DD, Esakof DD, Chaudhry GM, Symes JF, Isner JM.
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2793-800. PubMed ID: 9409257
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
    Mukhopadhyay D, Nagy JA, Manseau EJ, Dvorak HF.
    Cancer Res; 1998 Mar 15; 58(6):1278-84. PubMed ID: 9515816
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation.
    Walter DH, Hink U, Asahara T, Van Belle E, Horowitz J, Tsurumi Y, Vandlen R, Heinsohn H, Keyt B, Ferrara N, Symes JF, Isner JM.
    Lab Invest; 1996 Feb 15; 74(2):546-56. PubMed ID: 8780172
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases.
    Shulman K, Rosen S, Tognazzi K, Manseau EJ, Brown LF.
    J Am Soc Nephrol; 1996 May 15; 7(5):661-6. PubMed ID: 8738799
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Structural requirements for dimerization, glycosylation, secretion, and biological function of VPF/VEGF.
    Claffey KP, Senger DR, Spiegelman BM.
    Biochim Biophys Acta; 1995 Jan 05; 1246(1):1-9. PubMed ID: 7811723
    [Abstract] [Full Text] [Related]

  • 16. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.
    Senger DR, Ledbetter SR, Claffey KP, Papadopoulos-Sergiou A, Peruzzi CA, Detmar M.
    Am J Pathol; 1996 Jul 05; 149(1):293-305. PubMed ID: 8686754
    [Abstract] [Full Text] [Related]

  • 17. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes.
    Shen H, Clauss M, Ryan J, Schmidt AM, Tijburg P, Borden L, Connolly D, Stern D, Kao J.
    Blood; 1993 May 15; 81(10):2767-73. PubMed ID: 8490183
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Vascular permeability factor/vascular endothelial growth factor inhibits anchorage-disruption-induced apoptosis in microvessel endothelial cells by inducing scaffold formation.
    Watanabe Y, Dvorak HF.
    Exp Cell Res; 1997 Jun 15; 233(2):340-9. PubMed ID: 9194496
    [Abstract] [Full Text] [Related]

  • 20. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ.
    Clin Cancer Res; 2000 Mar 15; 6(3):957-65. PubMed ID: 10741721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.